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Ischemia/reperfusion (I/R) injury is a common cause of liver dysfunction during hepatectomy, liver transplantation procedures and
in generalized shock. Although effort has been dedicated to rescuing tissue damage in these clinical settings, there is still an urgent
need for an effective treatment to protect the liver from the burden of I/R injury. In this study, we have investigated the potential
clinical impact of unacylated-ghrelin (UnAG) in a liver I/R rat model. Particular attention has been paid to mitochondria. We
demonstrate that UnAG was able to reduce the lag-phase time in response to ADP administration and increase oxygen
consumption in ex vivo experiments using liver mitochondria recovered from rats subjected to I/R. Moreover, we found that UnAG
rescued the expression of a key regulator of mitochondrial morphology and electron transport chain function; the optic atrophy 1
(Opa1) protein. Cytochrome c oxidase (COX), ATP synthase (complex V) activity and mitochondrial permeability transition pore
(mPTP) opening were also affected by UnAG administration in vivo. An in vitro, hepatic I/R model was used to validate these data.
We demonstrate that UnAG upregulates the expression of Cox subunit IV (CoxIV) and increases cellular ATP content. This results in
Bcl-2 upregulation and protection against apoptosis. Opa1 silencing shows that Opa1 is crucial for a UnAG-induced increase in
cellular ATP content, apoptosis resistance, Bcl-2 and CoxIV expression. Finally, we show that UnAG improves Opa1’s interaction with
MIC60 in the I/R setting, hinting at its role in cristae shape regulation. Our results demonstrate that UnAG administration rescues the
intrinsic mitochondrial pathway triggered by I/R damage. Opa1’s contribution in mediating this effect is also reported. This suggests
that UnAG can interfere with mitochondrial dysfunction, via Opa1, in a preclinical liver I/R model. We therefore provide the rationale
for exploiting UnAG as an alternative means to rescuing mitochondrial damage and organ dysfunction.
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INTRODUCTION
Ischemic organ damage is a leading cause of morbidity and
mortality worldwide.1,2 Hepatic ischemia-reperfusion (I/R) injury
occurs in several clinical settings, including liver transplantation,
liver resection and systemic shock.3,4 Although liver transplanta-
tion is one of the most efficient treatments for end-stage hepatic
disease, up to 30% of primary graft dysfunction in this specific
clinical setting has been attributed to I/R injury.3 The term I/R
injury has been introduced to describe the initial tissue damage
caused by a deprivation of blood flow and oxygen and the
subsequent severe inflammatory responses in the early phase of
organ reperfusion. It is well established that mitochondria are the
central target of I/R injury.5 Mitochondria are powerhouse
organelles which are involved in the oxidative phosphorylation
(OXPHOS) process via the electron transport chain (ETC). This
translates into the energy-yielding metabolism of aerobic
organisms.6 The ETC drives and couples electrons flow to protons
pumping into the mitochondrial inter-membrane space, which
results in chemiosmotic gradient (Δψ) generation and furnishes
the free energy for ATP synthesis. ATP synthase, a membrane
protein complex that is also called ETC complex V, is the
machinery which phosphorylates ADP by bringing back protons.
The ETC is made up of four major respiratory complexes, besides
complex V. One of these, Cytochrome c oxidase (COX or complex
IV) is considered a key regulator of the whole OXPHOS, since it
acts as a final effector of the entire respiratory chain.7 In
physiological conditions, functional mitochondria require a
balance between fission and fusion as well as proper mitochon-
drial cristae density. Optic atrophy 1 (Opa1), a profusion dynamin-
related protein of the inner mitochondrial membrane (IM), is one
of the most important mediators of mitochondrial homeostasis.8
Data from Opa1 genetic silencing demonstrated its crucial role in
cristae organization and mitochondrial respiratory efficiency.9,10
A multi-subunit mitochondrial contact site and cristae organiz-
ing system (MICOS) complex has recently been described at
cristae junctions (CJ).11–13 MICOS has been shown to play a crucial
role in forming and maintaining the architecture of the
mitochondrial IM. The IM is an energy-coupling membrane and
the central site for cellular ATP production.14–16 The formation of
multimeric complexes, formed by Opa1 and MIC60, has more
recently been described as a crucial regulator of crista shape.17
It has been well documented that a lack of oxygen availability
during I/R damage results in ETC dysfunction and eventually in the
early exit of electrons and protons which, in turn, translates into
ROS production and diminished mitochondrial coupling
efficiency.18 Contextually, mitochondrial proteases activate and
degrade Opa1, which initiates a vicious cycle, including mitochon-
drial fission and fragmentation, that further leads to ATP
depletion, cell swelling and necrotic cell death.19 Owing to the
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crucial role that mitochondria play in mediating tissue damage in
the I/R setting, a great deal of effort has been dedicated to
identifying novel therapeutic options to protect mitochondria and
avoid I/R-associated adverse effects and organ failure. However,
none have succeeded.20,21
Unacylated-ghrelin (UnAG) is a form of ghrelin and is mainly
produced in the stomach.22 UnAG differs from acylated ghrelin
(AG) in terms of its biological activity and its molecular receptor
has yet to be characterized. UnAG is the more abundant
circulating form of ghrelin, which exerts anti-oxidant effects on
diabetic-derived endothelial progenitor cells.23 Moreover, UnAG
was also found to protect muscle and endothelial cells in I/R
preclinical models by regulating superoxide dismutase 2, a key
mitochondrial anti-oxidant enzyme.24,25 Evidence for the protec-
tive role that ghrelin plays against liver I/R damage has been
provided.3 Based on these considerations, the aim of the present
study is to investigate the impact of naturally occurring UnAG in
protecting the liver from I/R injury. Particular attention has been
paid to analyzing UnAG action on mitochondrial functions.
RESULTS
UnAG affects mitochondrial membrane potential (Δψ) and
respiration
In a physiological context, ETC activity eventually results in the
generation of an electrochemical gradient (Δψ) between the
mitochondrial matrix and the intermembrane space. Δψ drives
protons back to the matrix and this process is coupled with ATP
synthesis.26 The beneficial vascular and muscle effects reported in
ischemic settings in response to UnAG treatment,24,25 led us to
investigate its therapeutic potential in Wistar rat livers exposed
to I/R.
To this end, rats were injected with UnAG 15 min before I/R
induction. After 90 min, the clamp was removed and reperfusion
allowed for 2 h (Figure 1a). Mitochondria were collected and
analyzed for different functional parameters. As shown in
Figures 1b and c, while no significant alterations were observed
regarding mitochondrial membrane potential and ADP-induced
depolarization (Figure 1b), UnAG was able to reduce the lag phase
time in response to ADP administration (Figure 1c). These effects
are independent of UnAG binding to mitochondria as no
significant alterations were registered upon the incubation of
isolated mitochondria with UnAG (data not shown).
The oxygen consumption rate was evaluated in mitochondria
isolated from liver subjected to I/R and treated with UnAG since
mitochondria utilize oxygen to generate the membrane potential
and eventually ATP. It was found that the oxygen consumption
rate was negatively affected by ischemia during ADP-mediated
State 3 respiration, while it was completely reverted by UnAG
treatment (Figure 2a).
Data from mitochondrial respiration were further explored by
means of the highly informative respiratory control (R.C.R.) and
ADP/O ratio.27 It was observed that ADP/O ratio was increased by
UnAG (Figure 2b). This observation, along with the finding that
UnAG did not significantly change State 4 respiration (Figure 2c),
suggests that the increase in oxygen consumption relies on ATP
synthesis, rather than on an increase in proton leakage. In fact,
R.C.R. increased upon UnAG treatment (Figure 2d). UnAG was
therefore able to reduce I/R injury by improving mitochondrial
bioenergetic efficiency. This is consistent with the normalization of
transaminases level, alanine aminotransferase (ALT) and aspartate
aminotransferase (AST), in UnAG-treated animals. As shown in
Figures 2e and f, warm I/R significantly increased AST and ALT
plasma levels relative to the control group. UnAG was effective in
reducing the increase in the plasma levels of AST and ALT, as
caused by I/R.
UnAG improves specific ETC activity and increases CoxIV and Opa1
expression
Specific ETC complex activities were assessed in mitochondria
subjected to I/R damage in order to gain further insight into the
mechanisms that account for UnAG action. It was found that
UnAG improved COX functional activity, as shown by the oxygen
consumption rate (Figure 3a). By contrast, no differences were
detected when Complex II-succinate dehydrogenase-activity was
analyzed (data not shown). This indicates the crucial role played
by COX in sustaining the whole oxygen consumption rate
(Figures 2a and d). In addition, it was proved that UnAG increased
the reverse ATPase activity of mitochondrial ATPsynthase
(Figure 3b).
The observation that COX activity was increased by UnAG
treatment in an ischemic setting led us to investigate the levels of
the nuclear-encoded subunit CoxIV in hepatic mitochondria
recovered from untreated and treated-animals. As shown in
Figure 3c, it was found that UnAG increased CoxIV expression but
not that of CoxI and ATP synthase (data not shown).
Opa1 has recently emerged as an important regulator of the
mitochondrial IM fusion process, as well as that of OXPHOS
sensing and cristae remodeling.9,10 Opa1 content in mitochondria
was therefore assessed as a means to further analyze the
mechanisms of UnAG action. As shown in Figure 3d, ischemic
liver mitochondria displayed increased levels of Opa1 when
treated with UnAG.
UnAG protects hepatocytes against intrinsic apoptosis
Mitochondria are also crucial for the apoptotic process. ATP
deficiency leads to dysfunctional ATPase-mediated ion transport,
which contributes to an increase in intracellular and mitochondrial
calcium content. This, in turn, generates mitochondrial perme-
ability transition pore (mPTP) opening and Cytocrome c release,
resulting in the activation of the caspase cascade.28–31 Isolated
mitochondria from animals subjected to differing experimental
conditions were therefore additionally exposed to toxic calcium
concentrations and mPTP was assessed, as mitochondrial swelling,
in order to evaluate any possible UnAG contribution to protecting
cells from the increase in calcium content and the activation of the
apoptotic pathway. Cyclosporine A, which prevents mPTP open-
ing, was used as a negative control. As shown in Figure 3e,
delayed mPTP opening was found to occur in mitochondria
recovered from livers not exposed to I/R. By contrast, toxic calcium
concentration induced mPTP opening and osmotic swelling was
found in mitochondria recovered from I/R animals. It is worth
noting that calcium overload-mediated osmotic swelling was
partially prevented in mitochondria from UnAG-treated animals.
This suggests that UnAG may confer acquired resistance to mPTP
opening and possibly apoptosis.
UnAG effects are recapitulated in vitro
UnAG effects were investigated in an in vitro model of I/R damage
in order to validate the above ex vivo results. For this purpose,
cultured immortalized hepatocytes were serum deprived and
subjected to 24 h of in vitro ischemia followed by 3 h of oxygen
reperfusion (I/Reo) and then either treated with UnAG or left
untreated. UnAG upregulated CoxIV and Opa1 expression
(Figure 4a), as is consistent with the ex vivo data. This translated
into increased cellular ATP content (Figure 4b). Moreover, when
the expression of Bcl-2 and the number of apoptotic cells were
analyzed (Figures 4a and c), it was found that UnAG was able to
protect liver cells from the activation of the intrinsic apoptotic
pathway triggered by I/Reo, even in vitro.
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Opa1 is crucial for UnAG-mediated protection against I/Reo injury
The role of Opa1 in maintaining mitochondrial cristae structure to
avoid ATP production loss has been reported.32 siRNA technology
was used on cells subjected to I/Reo and UnAG treatment in order
to investigate the biological relevance of Opa1 in mediating UnAG
action on mitochondria. The results reported in Figure 5 clearly
demonstrate that UnAG action strictly depends on Opa1
expression in I/Reo conditions. Indeed, it was found that the
increase of both CoxIV and Bcl-2 expression was lost in cells
depleted of Opa1 and treated with UnAG (Figures 5a and b). As a
matter of fact, UnAG failed to increase cellular ATP content and
resistance to apoptosis in Opa1-depleted cells (Figures 5c and d).
It has been previously demonstrated that the interplay between
Opa1 and MIC60 is crucial for mitochondrial remodeling.33 We
therefore investigated whether this interplay could occur also in
our model. As shown in Figures 6a and b co-immunoprecipitation
experiments demonstrated that UnAG could also be able to
regulate cristae shape, in ischemic conditions, by increasing Opa1
content in the Opa1/MIC60 complex.
DISCUSSION
Liver I/R injury increases morbidity and mortality in clinical
settings, including liver transplantation, hepatic surgery and
hepatic failure after hemorrhagic shock.3,34 Mechanistically, liver
I/R injury is accompanied by impaired mitochondrial structure and
function, which leads to a decline in mitochondrial respiration and
enhanced ROS production.35,36 A number of therapeutic options
have been proposed, but have failed to improve long-term
outcomes.20,21,34 This failure to obtain a clinical response from
current therapeutic options has driven the development of
alternative strategies that are mainly focused on improving
antioxidant machinery. We have previously shown that UnAG,
the more abundant circulating form of ghrelin, exerts anti-oxidant
effects on numerous cell types,23–25 and a proof of concept for its
role in improving mitochondrial dysfunction has been reported in
preclinical settings of ischemic injury.24,25 In accordance with our
previous data, we have shown herein that UnAG improves
mitochondrial function in a rat model of hepatic I/R injury. Higher
oxygen consumption ensures better ATP availability, particularly
when there is a special need for energetic substrates to keep vital
cellular processes and escape apoptosis and necrosis. Further-
more, an efficient respiratory control index, ADP/O and state 3
respiration are crucial for mitochondria homeostasis.27 Our results
consistently demonstrate that I/R-induced ETC-metabolic impair-
ment and oxygen consumption rate are rescued by UnAG
administration. In line with this observation, it was found that
R.C.R. and the ADP/O ratio were increased in mitochondria
recovered from UnAG-treated animals. This suggests that UnAG
may reduce I/R injury by improving mitochondrial metabolic
functions. Mitochondria possess their own genome that encodes
ribosomal RNAs, transfer RNAs and proteins.37 These polypeptides
are the essential catalytic components of ETC complexes I, III and
IV and ATP synthase which form the OXPHOS.37 As expected,
dysfunctional mitochondria showed impaired oxidative phosphor-
ylation and ATP generation in hepatic I/R injury. By contrast, it was
found that in vivo UnAG treatment led to an improvement in ATP
synthase activity and to the increased expression of CoxIV, which
is mechanistically consistent with the enhancement of mitochon-
drial performance.
A lack of oxygen interferes with oxidative phosphorylation and
hampers ATP production, which, in turn, causes unbalanced
cytoplasmic ion levels, mainly involving Ca2+.38 Such derangement
translates into the activation of the intrinsic apoptosis pathway via
the mPTP opening. mPTP is a dynamic structure closed in the
ischemic period, while opened during reperfusion. mPTP opening
leads to membrane potential dissipation, uncoupled oxidative
phosphorylation, resulting in ATP depletion, and the release of
Figure 1. Evaluation of liver mitochondrial membrane potentials (Δψ) and lag phase time. (a) Hepatic I/R injury experimental design: 10 Wistar
rats underwent vascular clamp occlusion of the artery (ischemia), perfusing 70% of the liver. After 90 min of ischemia, the clamp was removed
and reperfusion allowed for 2 h. Animals were then killed and mitochondria were isolated from the 70% of liver exposed to I/R and from the
remaining 30%, which was used as an internal control. Either UnAG (100 μg/kg) or saline were injected into the hepatic artery 15 min before
ischemia. (b) TPP+ electrode traces of liver mitochondria recovered from animals subjected to I/R or not, either treated or untreated with
UnAG (100 μg/kg): at time 0 the mitochondrial preparation was energized with succinate, and Δψ quickly reached a physiological value. The
time required for ETC to reestablish a pre-phosphorilative Δψ value after ADP administration corresponds to the Lag Phase time. Data are
reported as mean± S.E.M. and representative of five different experiments, performed in triplicate (N= 5). (c) Quantitative analysis of the Lag
Phase time values, evaluated in liver mitochondria recovered from animals treated as indicated (*Po0.05 UnAG+I/R versus I/R). Data are
reported as mean± S.E.M. and representative of five different experiments, performed in triplicate (N= 5).
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apoptotic drivers, such as Cytochrome c.5,35,39 The protection of
mitochondrial function exerted by UnAG during liver I/R injury is
also sustained by the inhibition of mPTP opening, a reduction in
the number of apoptotic cells and increased Bcl-2 expression.
As a matter of fact, cellular ATP content is also increased upon
UnAG treatment. The suppression of glycogen synthase kinase
3β has been previously reported as a mechanism that
regulates hepatic mPTP opening in I/R injury.40 Although we did
not gain further insight into the molecular mechanism, our data
indicate that UnAG protection against I/R injury in the liver may be
the result of multiple mechanisms involving both the
improvement of mitochondrial respiratory capacity and apoptosis
resistance.
Mitochondria dynamically regulate their organization via
opposing fusion and fission processes to maintain bioenergetic
homeostasis and contribute to key cellular paths.8 Mitochondria
undergo fission to generate fragmented organelles required for
cell division and mitophagy, while they go through fusion to form
elongated interconnected networks which allow the renewal of
damaged mitochondrial DNA to occur.41 Although mitochondrial
fusion is orchestrated by different mitochondrial proteins, includ-
ing Mfn1, Mfn2 and Opa1, data from genetic ablation
Figure 2. UnAG improves liver mitochondria respiration. (a) Histogram representation of oxygen consumption during State 3 (that is, ADP
stimulated) respiration of liver mitochondria recovered from animals and treated as indicated (*Po0.05 UnAG+I/R versus I/R).Data are
reported as mean± S.E.M. and representative of five different experiments, performed in triplicate (N= 5). (b) Histogram representation of
ADP/O ratio on liver mitochondria, treated as indicated; the absolute value reflects the nmoles of ADP phoshorylated per oxygen atom
(*Po0.05 UnAG+I/R versus I/R). Data are reported as mean± S.E.M. and representative of five different experiments, performed in triplicate
(N= 5). (c) Histogram representation of oxygen consumption during post phosphorylative State 4 respiration on liver mitochondria, treated as
indicated. Data are reported as mean± S.E.M. and representative of five different experiments, performed in triplicate (N= 5). (d) Histogram
representation of Respiratory Control Ratio (R.C.R.), the normalized index of ETC performance, which is obtained by dividing State 3 to State 4
(*Po0.05 UnAG+I/R versus I/R). Data are reported as mean± S.E.M. and representative of five different experiments, performed in triplicate
(N= 5). (e, f) Histogram representation of plasmatic concentration (International Units per liter) of the hepatic ALT (e) and AST (f) enzymes (the
following both for ALT and AST: *Po0.05 UnAG+I/R versus I/R; *Po0.05 Ctrl versus UnAG+I/R and I/R). Data are reported as mean± S.E.M. and
representative of five different experiments, performed in triplicate (N= 5).
UnAG and liver mitochondria
A Rossetti et al
4
Cell Death Discovery (2017) 17077 Official journal of the Cell Death Differentiation Association
demonstrated that, unlike Opa1 deficiency which led to mito-
chondrial dysfunction,32 Mfn1 and Mfn2 rescued a deficiency in
one or the other at least in part. Genetic data are mechanistically
consistent with the role of Opa1 in maintaining cristae structure
within mitochondria, in preserving IM integrity and IM potential
and in avoiding the release of Cytochrome c from cristae.32
Therefore, increased content of Opa1 upon UnAG challenge might
play a key role for the enhanced mitochondrial performance
observed in our experimental model.
Opa1 has also been reported to promote CJ formation.9,42,43
Besides Opa1, MICOS has also recently been reported to play a
role in CJ biogenesis.17 As previously described in other tissue,17 it
was found herein that Opa1 and MIC60 physically interact and
that the amount of Opa1 in the molecular complex formed is
increased in response to UnAG in the I/R setting. Increased Opa1
in skeletal and cardiac muscle, the brain and liver, confer
remarkable protection against a widespread spectrum of tissue
injury.44 Moreover, Civiletto et al.45 have demonstrated that
increased Opa1 content can also ameliorate defective mitochon-
drial bioenergetics. Furthermore, Glytsou et al.17 have reported
that Opa1 epistatically influences core MIC60 in CJ biogenesis and
identified Opa1 as a key regulator of apoptotic cristae remodeling.
The MIC60/OPA1 complex is essential for mitochondrial CJ
formation and remodeling. OPA1 functionally interacts with
Figure 3. UnAG enhances specific ETC complex activities, induces CoxIV and Opa1 expression and promotes apoptosis resistance. (a)
Histogram representation of Cytochrome c oxidase (COX) activity in mitochondria recovered from I/R animals treated as indicated (*Po0.05
UnAG+I/R versus I/R). Data are reported as mean± S.E.M. and representative of four different experiments, performed in triplicate (N= 4). (b)
Histogram representation of ATPsynthase activity in mitochondria, treated as indicated, expressed by reverse ATPase activity (*Po0.05 UnAG
+I/R versus I/R). Data are reported as mean± S.E.M. and representative of five different experiments, performed in triplicate (N= 5). (c)
Mitochondria recovered from I/R animals, treated as indicated, were lysed and analyzed for CoxIV content, normalized to Tom20 (*Po0.05
UnAG+I/R versus I/R). Data are reported as mean± S.E.M. and representative of four different experiments, performed in triplicate (N= 4). (d)
Mitochondria recovered from animals, treated as indicated, were lysed and analyzed for Opa1 content, normalized to Tom20 (*Po0.05 UnAG
+I/R versus I/R). Data are reported as mean± S.E.M. and representative of three different experiments, performed in triplicate (N= 3). (e)
Evaluation of mitochondrial permeability transition pore (mPTP) opening of liver mitochondria isolated from animals, treated as indicated.
Calcium concentration (5 μM) was added to individual preparations. I/R+Cyclosporine A (CsA) was used as a negative control for mPTP
opening (*Po0.05 UnAG+I/R versus I/R from the 13th minute of assay). Data are reported as mean± S.E.M. and representative of five different
experiments, performed in triplicate (N= 5).
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MIC60, but such a complex is not necessary for CJ formation.17
Mitochondria are swollen and mitochondrial structure and
function are compromised after I/R, leading to a need for
remodeling.46 The protection afforded by the hormone, with
the previous administration of UnAG, prevents structural and
functional damage to the mitochondria population, which is
why there is a minor need for crosstalk between the cristae
regulators, OPA1/MIC60. This is supported by the work of Barrera
et al.,33 in which OPA−/− animals display an increase in MIC60
content.
In conclusion, the present study provides the first evidence that
UnAG may limit liver damage during I/R injury, upon acting on the
mitochondrial level where it is able to protect respiratory chain
function and to limit both ATP depletion and proton leak
(Figure 7). Prompt mitochondrial biogenesis has already been
suggested as a strategy for the clinical management of liver I/R
injury,47 and, in fact, our data suggest that UnAG may be exploited
as a new therapeutic option for the prevention of liver damage
and/or the targeting of primary mitochondrial disorders by
ameliorating mitochondrial bioenergetics.
MATERIALS AND METHODS
Reagents and antibodies
Reagents
Description: Purchased from:
Bovine calf serum albumin (BSA)
(A8806), FBS (F6178), SDS (L3771),
PIPES (P9291), Triton X-100 (T8787),
Nonidet P-40 (74385), NaCl (S3014),
NaF (S7920), Na3OV4 (S6508), Na4P2O7
(P8010), MgCl2 (M8266), KCl (P9541),
HCl (258148), Na-azide (S2002), HEPES
(H3375), Tris (T1503), EDTA (E6758),
EGTA (E4378), ethanol (51976), aproti-
nin (A6279), pepstatin A (P5318),
PMSF (P7626), DMSO (D8418), leupep-
tin (L2884), penicillin-streptomycin
(P4333), collagen (C9791), protein
A-Sepharose beads (P3391), L-glutam-
mine (G7513), Doxorubicin (D1515),
Mg2+-ATP (A9187), ADP (A2754), Suc-
cinate (S9637), Sucrose (S0389),
K2HPO4 (P5655), Rotenone (R8875),
Oligomycin (75351), carbonylcyanide-
p-trifluoromethoxyphenylhydrazon
(FCCP) (C2920), Cyclosporin A (C1832),
tetraphenylphosphorium (TPP+)
(218890), antimycin (A8674), KCN
(60178), ascorbate (A4034),
tetramethylphenylene-diamine
(TMPD) (T7394), phenazine methosul-
fate (PMS) (P9625), dibenzylfluores-
cein (DBF) (D7191), trichloracetic acid
(T9159), molybdate (A1343)
Sigma-Aldrich (St Louis, MO,
USA)
Protein molecular weight markers
(161-0374), Acrylammide (161-0156),
polyvinylidene difluoride (PVDF)
membranes (162-0115), Bradford
reagent (500-0205), ECL (170-5061)
Bio-Rad (Hercules, CA, USA)
Lipofectin Reagent (18292-037)
opti-MEM (11058021)
RPMI medium (31870-025)
Invitrogen (Life Technologies
Carlsbad, CA, USA; Paisley, UK).
UnAG Phoenix Pharmaceuticals (Bel-
mont, CA, USA)
Antibodies
Description: Purchased from:
anti β actin (sc-47778) S. Cruz Biotechnology (Heidel-
berg, Germany)
anti Opa1 (ab42364); Abcam (Cambridge, UK)
anti CoxIV(ab14744);
anti Bcl-2 (ab59348);
anti MIC60 (ab110329)
anti-rabbit IgG, HRP linked (4050-05)
anti-mouse IgG, HRP linked (1031-05)
Southern Biotech (Birmingham,
AL, USA)
Hepatic I/R rat model
Ten 16-week–old Wistar rats (Charles River, France) were maintained on a
standard laboratory diet. The animals were given food and water ad libitum
with a 12 h light/dark daily cycle and were acclimated for 1 week before
the start of the experiment. Animal studies were conducted in accordance
with the Portuguese National Institute of Health Guide for the Care and
Use of Laboratory Animals. All procedures were approved by the Ethics
Committee of the University of Coimbra. Rats were housed according with
the Federation of European Laboratory Animal Science Association
Guidelines. All experiments were performed in accordance with relevant
guidelines and regulations. Rats were randomly allocated to receive either
hepatic I/R or I/R plus UnAG (100 μg/kg, injected into hepatic artery 15 min
before ischemia).
Animals were anesthetized with ketamine (50 mg/kg) and chlorproma-
zine (50 mg/kg). A model of partial ischemia (70%) was used to prevent
mesenteric venous congestion by permitting portal decompression
through the right and caudate lobes. After a midline laparotomy, the
hepatic artery and portal vein to the left and median liver lobes were
occluded for 90 min. Reperfusion (2 h) was initiated by removal of the
clamp.48
Isolation of liver mitochondria
Animals were killed by cervical dislocation immediately after 2 h
reperfusion. Mitochondria were isolated via differential centrifugation, as
previously described49 and kept on ice all throughout the procedure. The
homogenization medium contained 250 mM sucrose, 10 mM HEPES (pH
7.4), 0.5 mM EGTA and 0.1% fat-free bovine serum albumin. EGTA and
bovine serum albumin were omitted from the final washing medium,
which was adjusted to pH 7.4. Briefly, after the homogenization of the
minced blood-free hepatic tissue, the homogenate was centrifuged at
500× g for 10 min at 4 °C. The resulting supernatant was spun at 10 000× g
for 10 min at 4 °C to pellet the mitochondria, which were resuspended in a
final washing medium. Protein content was determined using the Biuret
method,50 calibrated with bovine serum albumin.
Mitochondrial respiration
Oxygen consumption was polarographically determined using a Clark type
polarographic oxygen sensor, as previously described.49 Mitochondria
(1 mg) were suspended under constant stirring at 25 °C in 1 ml of standard
respiratory medium (130 mM sucrose, 50 mM KCl, 5 mM MgCl2, 5 mM
KH2PO4, 50 μM EDTA, and 5 mM HEPES (pH 7.4)) and energized by adding
glutamate/malate or succinate to a final concentration of 5 mM. Rotenone
(2 μM), an inhibitor of complex I, was added earlier to the succinate assays.
State 3 respiration was induced by adding 200 nmoles ADP. Oxygen
consumption was also measured in the presence of oligomycin (0.5 μg/mg
protein) and 1 μM carbonylcyanide-p-trifluoromethoxyphenylhydrazon
(FCCP). States 3 and 4 and respiratory control ratio (R.C.R.) were calculated
according to Chance and Williams.51 All experiments were performed in
triplicate.
Mitochondrial transmembrane potential (Δψ) measurements
Mitochondrial transmembrane potential (Δψ) was estimated using an ion-
selective electrode to measure the distribution of tetraphenylphosphorium
(TPP+) according to previously established methods.52,53 The voltage
response of the TPP+ electrode to log [TPP+] was linear with a slope of
59± 1, in conformity with the Nernst equation. Reactions were carried out
at 25 °C, in a temperature-controlled water-jacketed chamber with
magnetic stirring. Mitochondria (1 mg) were suspended in 1 ml of standard
respiratory medium (as in mitochondrial respiration), supplemented with
3 μM TPP+. A matrix volume of 1.1 μl/mg protein was assumed. All
experiments were performed in triplicate.
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Enzymatic activities
Succinate dehydrogenase activity was polarographically determined as
previously described.54 The reaction was carried out at 25 °C in 1.4 ml of
standard respiratory medium (as in mitochondrial respiration) supplemen-
ted with 5 mM succinate, 2 μM rotenone, 0.1 μg Antimycin A, 1 mM KCN
and 0.3 mg Triton X-100. After the addition of freeze-thawed mitochondria
(0.25 mg) the reaction was initiated with 1 mM phenazine methosulfate.
Cytochrome c Oxidase activity was polarographically determined, as
previously described.55 The reaction was carried out at 25 °C in 1.4 ml of
standard respiratory medium supplemented with 2 μM rotenone, 10 μM
oxidized Cytochrome c, 0.3 mg Triton X-100 and freeze-thawed mitochon-
dria (0.25 mg), after which the reaction was initiated by adding 5 mM
ascorbate plus 0.25 mM tetramethylphenylene-diamine.
ATPase activity was determined spectrophotometrically at 660 nm, in
association with ATP hydrolysis.56 The reaction was carried out at 37 °C, in
2 ml reaction medium (100 mM NaCl, 25 mM KCl, 5 mM MgCl2 and 50 mM
HEPES, pH7.4). After the addition of freeze-thawed mitochondria (0.25 mg),
dibenzylfluorescein was added and allowed to incubate for 3 min before
the initiation of the reaction with the addition of 2 mM Mg2+-ATP, in both
the presence or absence of oligomycin (1 μg/mg protein). The reaction was
stopped after 10 min by adding 1 ml of 40% trichloroacetic acid and the
samples were centrifuged (5 min, 3000 × g). 2 ml of ammoniummolybdate
(1%) plus 2 ml H2O were then added to 1 ml of supernatant and reacted
for 5 min at room temperature. ATPase activity was calculated as the
difference in total absorbance and the absorbance in the presence of
oligomycin. All experiments were performed in triplicate.
Measurement of the mitochondria permeability transition
Mitochondrial swelling was estimated by changes in light scattering, as
spectrophotometrically monitored at 540 nm.57 Reactions were carried out
at 25 °C. Experiments were started by the addition of mitochondria (1 mg)
to 2 ml of reaction medium (200 mM sucrose, 10 mM Tris-MOPS, 1 mM
KH2PO4, 10 μM EGTA, pH 7.4) supplemented with 3 μM rotenone, 0.5 μg
oligomycin,5 mM succinate and, in selected assays, Cyclosporin A 1 μM, a
known mPTP inhibitor as a negative control. After a brief period for the
recording of basal absorbance, toxic amount of Ca2+ (5 μM) was added and
the resulting alterations in light scattering were registered, as previously
described.57 All experiments were performed in triplicate.
Cell culture and in vitro I/Reo assay
A long-term stable hepatocyte cell line (RNT)58 was cultured in RPMI 1640
complete medium with 10% FBS (Lonza Group Ltd, Basel, Switzerland) in a
5% CO2 atmosphere at high density in collagen-coated flasks grown to
subconfluence prior to experiments. RNT cells were cultured for 24 h in
RPMI 1640 with 5% FBS either alone or in combination with UnAG (1 μM)
as indicated.24,25 On day 2, cells were subjected to in vitro ischemia, which
was induced by incubating cells in RPMI 1640 plus 2% FBS in a 5% CO2,
95% N2 humidified atmosphere, yielding 1% O2 concentrations for 24 h.
59
Subsequently, cells were reoxygenated with 75% N2, 20% O2and 5% CO2
for 3 h.59
ATP content assay
ATP content was performed using an ATP assay kit, according to the
manufacturer’s instructions (Sigma-Aldrich), to determine the level of
cellular ATP content as an indirect measurement of viable cells. Briefly,
RNT cells, that were treated as indicated, were subjected to in vitro
ischemia for 24 h as described above. After reoxygenation, ATP was
quantitatively determined by measuring luminescence generated in an
ATP-dependent luciferin-luciferase bioluminescence assay. A standard
Figure 4. UnAG upregulates Opa1 expression resulting in ATP production and apoptosis resistance during in vitro ischemia/reoxygenation (I/
Reo). (a) Cell extracts from RNT cells subjected to in vitro ischemia/reoxygenation (I/Reo), treated as indicated, were analyzed for Opa1, CoxIV
and Bcl-2 content, normalized to β actin content (for Opa1 and Bcl-2, *Po0.05 UnAG+I/Reo versus I/Reo; for CoxIV, *Po0.05 UnAG versus Ctrl
and *Po0.05 UnAG+I/Reo versus I/Reo). Data are reported as mean± S.E.M. and representative of three different experiments, performed in
triplicate (N= 3). (b) Histogram representation of the relative cellular ATP content. Data are obtained from RNT cells, treated as indicated
(*Po0.05 UnAG+I/Reo versus I/Reo). Data are reported as mean± S.E.M. and representative of four different experiments, performed in
triplicate (N= 4). (c) Apoptosis assay was performed on RNT cells subjected to I/Reo treated as indicated. Doxorubicin (1 μM) was used as a
positive control (*Po0.05 UnAG+I/Reo versus I/Reo). Data are expressed as percentage± S.E.M. of total apoptotic cells, and representative of
three different experiments, performed in triplicate (N= 3).
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curve was used in each experiment and the samples were diluted to be in
the linear range of the standard curve. All experiments were performed in
triplicate.
Silencing of the endogenous Opa1 by small interfering RNAs
(siRNAs)
RNT cells were transiently transfected with siRNA for Opa1, or with duplex
siRNAs (Qiagen, Valencia, CA, USA),25 and treated as indicated in order to
obtain Opa1 inactivation. Transfection was performed according to the
manufacturer’s instructions. Whole cell extracts were processed 48 h after
transfection. Cell viability was evaluated at the end of each experiment.
Western blot analysis
Cells were lysed (50 mM Tris-HCl (pH 8.3), 1% Triton X-100, 10 mM PMSF,
100 U/ml aprotinin, 10 μM leupeptin) and protein concentrations were
obtained, as previously described. Proteins (50 μg) were subjected to SDS-
PAGE, transferred onto nitrocellulose membranes, blotted with the
indicated antibodies and revealed using an enhanced chemiluminescence
detection system.25 Densitometric analysis was used to calculate the
differences in the fold induction of protein levels and normalized to β-
actin. Values are reported as relative amounts and all experiments were
performed in triplicate.
Immunoprecipitation
Protein concentration was determined using the Bradford dye-binding
procedure. Equal amounts of cell extracts (1 mg) were immunoprecipitated
with the indicated antibody and immunocomplexes were bound to
protein-A-Sepharose beads and recovered by centrifugation.60 Bound
material was eluted by boiling beads in 1% SDS, then separated on 8%
SDS-PAGE in reducing conditions and processed as described in the
western blot section. All experiments were performed in triplicate.
Apoptosis assay
For apoptosis assay, RNT cells, cultured in different experimental
conditions, were subjected to Muse Annexin V and cell dead assay (Merck,
Figure 5. Opa1 is required for UnAG-mediated protection against I/R injury. (a, b) Cell extracts from either Opa1-silenced or control RNT cells,
treated as indicated, were analyzed for Opa1,CoxIV and Bcl-2 content, normalized to β actin content (for Opa1 and Bcl-2, *Po0.05 UnAG+I/
Reo versus I/Reo; for Cox IV, *Po0.05 UnAG versus Ctrl and*Po0.05UnAG+I/Reo versus I/Reo). Data are reported as mean± S.E.M. and
representative of four different experiments, performed in triplicate (N= 4). Figure b has been cropped. (c) Histogram representation of the
relative cellular ATP content. Data are obtained from cells, treated as indicated (*Po0.05 UnAG+I/Reo versus I/Reo). Data are reported as
mean± S.E.M. and representative of four different experiments, performed in triplicate (N= 4). (d) Apoptosis assay was performed on RNT cells
subjected to I/Reo, treated as indicated. Doxorubicin (1 μM) was used as a positive control (*Po0.05 UnAG+I/Reo versus I/Reo). Data are
reported as percentage± S.E.M. of total apoptotic cells, and representative of four different experiments, performed in triplicate (N= 4).
UnAG and liver mitochondria
A Rossetti et al
8
Cell Death Discovery (2017) 17077 Official journal of the Cell Death Differentiation Association
Darmstadt, Germany) in accordance with the manufacturer’s instructions.
All experiments were performed in triplicate.
ALT and AST level determination
Plasma samples were collected immediately after the killing and enzymatic
determinations of ALT and AST were performed using commercial kits
(Hospitex Diagnostics). All experiments were performed in triplicate.
Statistical analysis
Data are represented as a mean of n⩾ 3 ± S.E.M., while statistical
significance was determined using the one-way (two-way for the swelling
analysis) ANOVA test with a Bonferroni correction (GraphPad Prism
software, La Jolla, CA, USA). A value of po0.05 (*) was considered
statistically significant. According to our previous data, the minimum
sample size that will permit us to detect a 30% difference between the
experimental groups, with 90% power and a probability level of 0.05 in a
two-tailed hypothesis, was n=5 rats/group.
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